Literature DB >> 20007382

Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Margot E Grinwis1, Christopher D Sibley, Michael D Parkins, Christina S Eshaghurshan, Harvey R Rabin, Michael G Surette.   

Abstract

With the recent insights into the Streptococcus milleri group (SMG) as pulmonary pathogens in patients with cystic fibrosis (CF), we sought to characterize 128 isolates from the sputum of adults with CF, along with 45 isolates from patients with invasive diseases for comparison. The tests performed included Lancefield grouping; tests for hemolysis; tests for the production of hyaluronidase, chondroitin sulfatase, DNase, proteases, and hydrogen peroxide; and PCR for the detection of the intermedilysin gene (ily). We also generated biochemical profiles with the Rapid ID Strep 32 API system and tested cell-free supernatants for the presence of the signal molecule autoinducer-2 (AI-2) using a Vibrio harveyi bioassay with a subset of CF strains. The S. intermedius isolates from both strain collections were similar, while the S. constellatus and S. anginosus isolates yielded several biotypes that differed in prevalence between the two strain collections. Beta-hemolytic, Lancefield group C S. constellatus comprised 74.4% of the S. constellatus isolates from patients with CF but only 13.3% of the corresponding isolates from patients with invasive infections. This was the only S. constellatus biotype associated with pulmonary exacerbations. Hyaluronidase-positive S. anginosus was detected only among the isolates from patients with CF. Strain-to-strain variability in AI-2 expression was evident, with the mean values being the highest for S. anginosus, followed by S. constellatus and then S. intermedius. Cluster analysis and 16S rRNA sequencing revealed that the species of SMG could be accurately determined with a minimum of three phenotypic tests: tests for the Lancefield group, hyaluronidase production, and chondroitin sulfatase production. Furthermore, isolates from patients with invasive infections clustered with isolates from the sputum of patients with CF, suggesting that the respiratory tract isolates were equally pathogenic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007382      PMCID: PMC2815602          DOI: 10.1128/JCM.01807-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  A numerical taxonomic study of the "Streptococcus milleri" group based upon conventional phenotypic tests and pyrolysis mass spectrometry.

Authors:  T G Winstanley; J T Magee; D I Limb; J M Hindmarch; R C Spencer; R A Whiley; D Beighton; J M Hardie
Journal:  J Med Microbiol       Date:  1992-03       Impact factor: 2.472

2.  Occurrence and cultural features of Streptococcus milleri in various body sites.

Authors:  P M Poole; G Wilson
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

3.  Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection.

Authors:  J A Jacobs; E E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

4.  The Streptococcus milleri group as a cause of pulmonary infections.

Authors:  T Shinzato; A Saito
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

5.  A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe.

Authors:  T Shinzato; A Saito
Journal:  J Med Microbiol       Date:  1994-02       Impact factor: 2.472

6.  The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources.

Authors:  L C Ball; M T Parker
Journal:  J Hyg (Lond)       Date:  1979-02

7.  Multiple signalling systems controlling expression of luminescence in Vibrio harveyi: sequence and function of genes encoding a second sensory pathway.

Authors:  B L Bassler; M Wright; M R Silverman
Journal:  Mol Microbiol       Date:  1994-07       Impact factor: 3.501

8.  Extracellular deoxyribonuclease production by anaerobic bacteria.

Authors:  R K Porschen; S Sonntag
Journal:  Appl Microbiol       Date:  1974-06

9.  Biochemical properties of CO2-dependent streptococci.

Authors:  L Pulliam; R K Porschen; W K Hadley
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

10.  Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci.

Authors:  P H Summanen; M-C Rowlinson; J Wooton; S M Finegold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-04       Impact factor: 3.267

View more
  16 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions.

Authors:  Jessie E Scott; George A O'Toole
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

3.  Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.

Authors:  Sarah Tavernier; Aurélie Crabbé; Mayram Hacioglu; Liesbeth Stuer; Silke Henry; Petra Rigole; Inne Dhondt; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 4.  The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.

Authors:  Yvonne J Huang; Susan V Lynch
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

5.  The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity.

Authors:  Christopher D Sibley; Kristen A Sibley; Tara A Leong; Margot E Grinwis; Michael D Parkins; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

6.  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

7.  Heterologous expression of sahH reveals that biofilm formation is autoinducer-2-independent in Streptococcus sanguinis but is associated with an intact activated methionine cycle.

Authors:  Sylvio Redanz; Kerstin Standar; Andreas Podbielski; Bernd Kreikemeyer
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

8.  The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.

Authors:  Laurence Delhaes; Sébastien Monchy; Emilie Fréalle; Christine Hubans; Julia Salleron; Sylvie Leroy; Anne Prevotat; Frédérick Wallet; Benoit Wallaert; Eduardo Dei-Cas; Telesphore Sime-Ngando; Magali Chabé; Eric Viscogliosi
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Phylogenetic relationship and virulence inference of Streptococcus Anginosus Group: curated annotation and whole-genome comparative analysis support distinct species designation.

Authors:  Adam B Olson; Heather Kent; Christopher D Sibley; Margot E Grinwis; Philip Mabon; Claude Ouellette; Shari Tyson; Morag Graham; Shaun D Tyler; Gary Van Domselaar; Michael G Surette; Cindi R Corbett
Journal:  BMC Genomics       Date:  2013-12-17       Impact factor: 3.969

10.  Host cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group.

Authors:  Julienne C Kaiser; Chris P Verschoor; Michael G Surette; Dawn M E Bowdish
Journal:  BMC Infect Dis       Date:  2014-09-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.